Trial Details

COMPLETED
Basic Information
Clinical ID c3806
Identifier NCT01505777
Trial Title Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome Without Diarrhea
Interventions DRUG: Probiotics (Medirac)|DRUG: Probiotics (Medirac)|DRUG: Probiotics (Medirac)|DRUG: Probiotics (Medirac)|DRUG: Probiotics (Medirac) placebo/mosapride placebo
Participant Information
Sponsor Hanmi Pharmaceutical Company Limited
City Seoul
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2011-05
Primary Completion Date 2012-06
Completion Date 2012-06